Addex Therapeutics (XSWX:ADXN) Cash from Discontinued Operating Activities : CHF0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Addex Therapeutics Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Addex Therapeutics's Cash from Discontinued Operating Activities for the three months ended in Dec. 2023 was CHF0.00 Mil. It means Addex Therapeutics received CHF0.00 Mil from discontinued investing activities. Addex Therapeutics's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.00 Mil.

Addex Therapeutics Cash from Discontinued Operating Activities Historical Data

The historical data trend for Addex Therapeutics's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Cash from Discontinued Operating Activities Chart

Addex Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash from Discontinued Operating Activities

Get a 7-Day Free Trial

Addex Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash from Discontinued Operating Activities	Get a 7-Day Free Trial															-	-	-	-	-

Addex Therapeutics Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0.00 Mil.

Addex Therapeutics Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Addex Therapeutics (XSWX:ADXN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » Cash from Discontinued Operating Activities

Comparable Companies

Traded in Other Exchanges

ADXN:USA ADXNz:UK APE1:Germany

Address

Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202

Website

https://www.addextherapeutics.com

Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (XSWX:ADXN) Headlines

From GuruFocus

Thinking about buying stock in Applovin, Sonos, WiMi Hologram Cloud, Addex Therapeutics, or Snap?

By PRNewswire PRNewswire • 02-09-2023

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire • 02-24-2021